SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001172661-24-004696
Filing Date
2024-11-13
Accepted
2024-11-13 16:52:02
Documents
1

Document Format Files

Seq Description Document Type Size
1 walleye-uncy093024.htm SC 13G 52919
  Complete submission text file 0001172661-24-004696.txt   54533
Mailing Address 315 PARK AVE S FLOOR 18 NEW YORK NY 10010
Business Address 315 PARK AVE S FLOOR 18 NEW YORK NY 10010 9523455200
Walleye Capital LLC (Filed by) CIK: 0001758720 (see all company filings)

IRS No.: 202560520 | State of Incorp.: MN
Type: SC 13G

Mailing Address 4300 EL CAMINO REAL, SUITE 210 LOS ALTOS CA 94022
Business Address 4300 EL CAMINO REAL, SUITE 210 LOS ALTOS CA 94022 650-384-0642
Unicycive Therapeutics, Inc. (Subject) CIK: 0001766140 (see all company filings)

IRS No.: 813638692 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-92874 | Film No.: 241455296
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)